Europe Alzheimer's Disease Therapeutics And Diagnostics Market Forecast 2018-2026

Publisher Name :
Date: 23-Apr-2018
No. of pages: 4

Key Findings

The Europe Alzheimer's disease therapeutics and diagnostics market is likely to progress with a 7.62% CAGR over the forecast period of 2018-2026.The region is expected to primarily become a market for generics by 2020 as currently the introduction of generic equivalents of AD therapeutics into the European market has peaked considerably.

Market Insights

The United Kingdom Alzheimer's disease therapeutics and diagnostics market is mainly driven by the heavy investment made by the government in research for neurodegenerative disease and government's Alzheimer research conferences to promote the awareness of Alzheimer disease. In France, the market growth is propelled by rising number of studies on Alzheimer's disease. The German market is expected to dominate this region due to the high prevalence of this diseases in its geriatric population while the Spanish Alzheimer's disease therapeutics and diagnostics market is primarily being driven by government approvals on strategies for neurodegenerative diseases.

Competitive Insights

Merck And Co, Siemens Medical Solutions, Amarantus Bioscience Holdings Inc, Pfizer Inc, Baxter International Inc, Axon Neuroscience Se, F. Hoffmann-La Roche Ag, Ge Healthcare, Abbvie Inc, Diagenic Asa and Cognoptix Inc are few of the established companies in this market.

Europe Alzheimer's Disease Therapeutics And Diagnostics Market Forecast 2018-2026

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Computed Tomography Is Majorly Used In The Diagnostics of Alzheimer's Disease
3.2.2. Therapeutics Market Constitutes The Largest Market Share
4. Market Determinants
4.1. Market Drivers
4.1.1. Growing Geriatric Population
4.1.2. Rise In The Pervasiveness of Alzheimer's Disease
4.1.3. Increasing Healthcare Expenditure
4.1.4. Government Investment In Research And Development
4.2. Market Restraints
4.2.1. Stringent Government Regulations
4.2.2. High Cost of Therapies Used For The Treatment of Alzheimer's Disease
4.3. Market Opportunities
4.3.1. Advancements In In-Vitro Diagnostic Techniques
4.3.2. Increasing R&D Investment In The Personalized Medicines
4.4. Market Challenges
4.4.1. Lack of Skilled Medicinal Practitioners Fot The Treatment of Alzheimer's Disease
4.4.2. Dearth of Awareness Concerning New Therapies In The Alzheimer's Disease
5. Market Segmentation
5.1. Market By Therapeutics And Diagnostic 2018-2026
5.1.1. Therapeutics
5.1.1.1. Therapeutics By Drugs
5.1.1.1.1. Marketed Drugs
5.1.1.1.2. Pipeline Drugs
5.1.1.2. Therapeutics By Disease Stage
5.1.1.2.1. Late Stage: Severe Ad
5.1.1.2.2. Early/Middle Stage: Mild To Moderate Ad
5.1.1.2.3. Prodromal Stage
5.1.1.3. Therapeutics By Generic And Branded
5.1.1.3.1. Branded
5.1.1.3.2. Generic
5.1.2. Diagnostics
5.1.2.1. Lumbar Puncture Test
5.1.2.2. Positron Emission Tomography
5.1.2.3. Electroencephalography
5.1.2.4. Magnetic Resonance Imaging
5.1.2.5. Computed Tomography
5.1.2.6. Other Diagnostics
6. Key Analytics
6.1. Porter's Five Force Model
6.1.1. Threat of New Entrants
6.1.2. Threats of Substitute Product
6.1.3. Bargaining Power of Buyer
6.1.4. Bargaining Power of Supplier
6.1.5. Intensity of Competitive Rivalry
6.2. Key Buying Criteria
6.2.1. Price
6.2.2. Efficiency
6.2.3. Safety
6.3. Etymology of Alzheimer's Disease Therapeutics And Diagnostics Market
6.4. Parent Market Analysis
6.5. Investments Analysis
6.5.1. Research And Development
6.5.2. Raw Materials
6.5.3. Manufacturing
6.5.4. Wholesalers
6.5.5. End User
6.6. Regulatory Framework
6.7. Europe Regulatory Agency
6.8. Alzheimer's Disease Etiology
6.9. Phases And Sternness of Alzheimer's Disease
6.10. Pipeline Analysis
6.11. Companion Diagnostics
7. Geographical Analysis
7.1. Europe
7.1.1. The United Kingdom
7.1.2. France
7.1.3. Germany
7.1.4. Spain
7.1.5. Rest of Europe
8. Company Profiles
8.1. Competitive Landscape
8.1.1. Market Share Analysis
8.2. Abbvie Inc.
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Scot Analysis
8.2.4. Strategic Initiatives
8.3. Amarantus Bioscience Holdings, Inc.
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Axon Neuroscience Se
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Scot Analysis
8.4.4. Strategic Initiative
8.5. Baxter International Inc.
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.6. Biogen Inc.
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Scot Analysis
8.6.4. Strategic Initiatives
8.7. Cognoptix Inc.
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Diagenic Asa
8.8.1. Company Overview
8.8.2. Product Portfolio
8.8.3. Scot Analysis
8.9. F. Hoffmann-La Roche Ag
8.9.1. Company Overview
8.9.2. Product Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Ge Healthcare
8.10.1. Company Overview
8.10.2. Product Portfolio
8.10.3. Scot Analysis
8.10.4. Strategic Initiatives
8.11. Merck And Co.
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Scot Analysis
8.11.4. Strategic Initiatives
8.12. Pfizer Inc.
8.12.1. Company Overview
8.12.2. Product Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Analysis
8.13. Piramal Enterprises Ltd.
8.13.1. Company Overview
8.13.2. Product Portfolio
8.13.3. Scot Analysis
8.13.4. Strategic Initiatives
8.14. Siemens Medical Solutions
8.14.1. Company Overview
8.14.2. Product Portfolio
8.14.3. Scot Analysis
8.14.4. Strategic Initiatives
8.15. Sun Pharma
8.15.1. Company Overview
8.15.2. Product Portfolio
8.15.3. Scot Analysis
8.15.4. Strategic Initiatives

List of Tables

Table 1 Europe Alzheimer's Disease Therapeutics And Diagnostics Market 2018-2026 ($ Million)
Table 2 Pharmacological Treatment of Behavioral And Psychological Symptoms of Dementia (Bpsd) of Alzheimer's
Table 3 Different Biomarkers Related To The Alzheimer's Disease
Table 4 Europe Alzheimer's Disease Therapeutics And Diagnostics Market 2018-2026 ($ Million)
Table 5 Europe Alzheimer's Disease Therapeutics And Diagnostics Market In Therapeutics By Drugs 2018-2026 ($ Million)
Table 6 Europe Alzheimer's Disease Therapeutics Market In Marketed Drugs 2018-2026 ($ Million)
Table 7 Europe Alzheimer's Disease Therapeutics Market In Pipeline Drugs 2018-2026 ($ Million)
Table 8 Europe Alzheimer's Disease Therapeutics And Diagnostics Market In Disease Stage By Drugs 2018-2026 ($ Million)
Table 9 Europe Alzheimer's Disease Therapeutics Market In Late Stage: Severe Ad 2018-2026 ($ Million)
Table 10 Europe Alzheimer's Disease Therapeutics Market In Early/Middle Stage: Mild To Moderate Ad 2018-2026 ($ Million)
Table 11 Europe Alzheimer's Disease Therapeutics Market In Prodromal Stage 2018-2026 ($ Million)
Table 12 Europe Alzheimer's Disease Therapeutics And Diagnostics Market In Therapeutics By Generic And Branded 2018-2026 ($ Million)
Table 13 Europe Alzheimer's Disease Therapeutics Market In Branded 2018-2026 ($ Million)
Table 14 Europe Alzheimer's Disease Therapeutics Market In Generic 2018-2026 ($ Million)
Table 15 Europe Alzheimer's Disease Therapeutics And Diagnostics Market By Types 2018-2026 ($ Million)
Table 16 Europe Alzheimer's Disease Diagnostics Market In Lumbar Puncture Test 2018-2026 ($ Million)
Table 17 Europe Alzheimer's Disease Diagnostics Market In Positron Emission Tomography 2018-2026 ($ Million)
Table 18 Europe Alzheimer's Disease Diagnostics Market In Electroencephalography 2018-2026 ($ Million)
Table 19 Europe Alzheimer's Disease Diagnostics Market In Magnetic Resonance Imaging 2018-2026 ($ Million)
Table 20 Europe Alzheimer's Disease Diagnostics Market In Computed Tomography 2018-2026 ($ Million)
Table 21 Europe Alzheimer's Disease Diagnostics Market In Other Diagnostics 2018-2026 ($ Million)
Table 22 Europe Alzheimers Disease Therapeutics And Diagnostic Market 2018-2026
Figures List
Figure 1 Europe Alzheimer's Disease Therapeutics And Diagnostics Market 2018-2026 ($ Million)
Figure 2 Costs of Care For People With Alzheimer's And Other Dementias 2017 ($ Billion)
Figure 3 Europe Alzheimer's Disease Therapeutics And Diagnostics Market In Therapeutics 2018-2026 ($ Million)
Figure 4 Europe Alzheimer's Disease Therapeutics And Diagnostics Market In Diagnostics2018-2026 ($ Million)
Figure 5 Investments In Alzheimer's Disease Treatment
Figure 6 Alzheimer's Drugs In The Pipeline By Treatment Focus (Number of Drugs)
Figure 7 Europe Alzheimers Disease Therapeutics And Diagnostic Market 2018-2026
Figure 8 The United Kingdom Alzheimers Disease Therapeutics And Diagnostic Market 2018-2026
Figure 9 France Alzheimers Disease Therapeutics And Diagnostic Market 2018-2026
Figure 10 Germany Alzheimers Disease Therapeutics And Diagnostic Market 2018-2026
Figure 11 Spain Alzheimers Disease Therapeutics And Diagnostic Market 2018-2026
Figure 12 Rest of Europe Alzheimers Disease Therapeutics And Diagnostic Market 2018-2026
Figure 13 Market Share Analysis of Alzheimer's Disease Therapeutics And Diagnostics Market 2017 (%)
  • Global Alzheimer's Disease Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Alzheimer's Disease Drug market size was valued at US$ 3539.3 million in 2023. With growing demand in downstream market, the Alzheimer's Disease Drug is forecast to a readjusted size of US$ 3943.3 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Alzheimer's Disease Drug market. Alzheimer's Disease Drug are expected to show stable growth in the future m......
  • Alzheimer's Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 97
    The global Alzheimer's Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Alzheimer's Drugs in various end use industries. The expanding demands from the Under 65 Years Old and 65 and Above 65 Years Old, are propelling Alzheimer's Drugs market. Acetylcholinesterase (AChE) Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by t......
  • Alzheimer Disease Drugs Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 111
    This study focuses on China's Alzheimer Disease Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and servi......
  • Alzheimer Disease Drugs Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 74
    This study focuses on China's Alzheimer Disease Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumpt......
  • Alzheimer Disease Drugs Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 239
    China's demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacit......
  • Global Alzheimer's Disease Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Sep-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Alzheimer's Disease Drug market: According to our latest research, the global Alzheimer's Disease Drug market looks promising in the next 5 years. As of 2022, the global Alzheimer's Disease Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Alzheimer's disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills and,......
  • Global Dementia and Movement Disorder Treatment Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 110
    Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality changes, difficulty in performing activities, loss of memory, and aphasia. Market Analysis and Insights: Global Dementia and Movement Disorder Treatment Market The global Dementia and Movement......
  • Global Nicergoline Market Insights, Forecast to 2029
    Published: 04-Jul-2023        Price: US 4900 Onwards        Pages: 112
    The global Nicergoline market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Nicergoline is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Nicergoline is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR......
  • Global Oxiracetam Market Research Report 2023
    Published: 21-Apr-2023        Price: US 2900 Onwards        Pages: 69
    Highlights The global Oxiracetam market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Oxiracetam is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. Asia-Pacific ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs